Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
|Articles|October 8, 2021
Pharmacy Clinical Pearl of the Day: Tonsillitis
Author(s)Saro Arakelians, PharmD
Tonsillitis most commonly affects children between preschool ages and the mid-teenage years.
Advertisement
Clinical Pearl of the Day: Tonsillitis
Tonsillitis is inflammation of the tonsils, 2 oval-shaped pads of tissue at the back of the throat—1 tonsil on each side.
Insight:
- Tonsillitis most commonly affects children between preschool ages and the mid-teenage years.
- Symptoms may include red and swollen tonsils, white or yellow coating on the tonsils, sore throat, fever, enlarged and tender glands, bad breath, stomachache, neck pain or stiff neck, and headache.
- Risk factors include young age of 5 to 15 years, and frequent exposure to germs.
- Diagnosis may include throat swab and complete blood count test.
- Treatments may include antibiotics, such as penicillin for 10 days, and surgery, such as tonsillectomy.
- Sources:
Advertisement
Related to this article
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
2
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
5